Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et al. Geller S. J Invest Dermatol 2025 Jun 24:S0022-202X(25)00542.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Geller S. Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et al. J Invest Dermatol 2025 Jun 24:S0022-202X(25)00542.
PMID: 40586749